SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000093751-24-000778
Filing Date
2024-10-17
Accepted
2024-10-17 09:36:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 Halozyme_Thera_Inc.htm SC 13G 54125
  Complete submission text file 0000093751-24-000778.txt   56266
Mailing Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114
Business Address 1 CONGRESS STREET SUITE 1 BOSTON MA 02114 617 786-3000
STATE STREET CORP (Filed by) CIK: 0000093751 (see all company filings)

IRS No.: 042456637 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G
SIC: 6022 State Commercial Banks
(CF Office: 02 Finance)

Mailing Address 12390 EL CAMINO REAL SAN DIEGO CA 92130
Business Address 12390 EL CAMINO REAL SAN DIEGO CA 92130 (858) 794-8889
HALOZYME THERAPEUTICS, INC. (Subject) CIK: 0001159036 (see all company filings)

IRS No.: 880488686 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-78830 | Film No.: 241376156
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)